Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Slides:

Advertisements

Similar presentations

Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study Evgenij V Potapov, MD, Heinz R Zurbrügg,

Advertisements

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Aprotinin improves pulmonary function during reperfusion in an isolated lung model Menen A Mathias, MD, Curtis G Tribble, MD, Jeffrey F Dietz, BS, Richard.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Cumulative Corticosteroid Exposure and Infection Risk After Complex Pediatric Cardiac Surgery Christopher W. Mastropietro, MD, Renee Barrett, MD, Maria.

Eradication of Aortic Infections With the Use of Cryopreserved Arterial Homografts Paul R. Vogt, MD, Ludwig K. von Segesser, MD, Yves Goffin, MD PhD,

Homograft failure in mycotic aortic aneurysm caused by streptococcus pneumoniae Pascal A Berdat, MD, Raffaele Malinverni, MD, Beat Kipfer, MD, Thierry.

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Prediction of severe acute kidney injury after pediatric cardiac surgery with the use of novel biomarkers: A new trend in clinical research and risk stratification

Immunology and failure of valved allografts in children

Closure of a Bronchopleural Fistula Using Decalcified Human Spongiosa and a Fibrin Sealant William R Baumann, Jack L Ulmer, Paul G Ambrose, Michael J.

Reduction of heparin dose is not beneficial to platelet function

Hyde M. Russell, MD, Soraya L. Johnson, BS, Katherine C

Modified Ultrafiltration Attenuates Dilutional Coagulopathy in Pediatric Open Heart Operations Robert H Friesen, David N Campbell, David R Clarke, Michael.

Prospective, Randomized, Double-Blind Study of High-Dose Aprotinin in Pediatric Cardiac Operations Michael J Davies, FRCS, Alison Allen, BScHons, Henry.

James L Zellner, MD, Scott B Kribbs, BS, B

Comparison of troponin-I and troponin-T after pediatric cardiovascular operation Franz F Immer, MD, Franco P Stocker, MD, Andrea M Seiler, MD, Jean-Pierre.

Current determinants of operative mortality in 1400 patients requiring aortic valve replacement Ines Florath, PhD, Ulrich P Rosendahl, MD, Amir Mortasawi,

Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization Hiroshi Kumano, MD, PhD, Shigefumi Suehiro, MD, PhD, Koji.

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Postoperative diaphragmatic hernia after use of the right gastroepiploic artery for coronary artery bypass grafting Miralem Pasic, MD, PhD, Thierry Carrel,

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Who Do You Say You Are? The Annals of Thoracic Surgery

Managing Fibrinolysis Without Aprotinin

Rejection with heart failure after pediatric cardiac transplantation

Use of Amiodarone After Major Lung Resection

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Kuthan Kavakli, MD, Deniz Dogan, MD, Sedat Gurkok

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Pediatric open heart operations without diagnostic cardiac catheterization Jean-Pierre Pfammatter, MD, Pascal A Berdat, MD, Thierry P Carrel, MD, Franco.

T. Carrel, MD, M. Pasic, MD, U. Niederhäuser, MD, M. Turina, MD

Pathology of the Radial and Internal Thoracic Arteries Used as Coronary Artery Bypass Grafts Eric Kaufer, BS, Stephen M Factor, MD, Rosemary Frame, MS,

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Jurg Schmidli, MD, Paul R. Vogt, MD, Michele Genoni, MD, Marko I

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J

Is there a role for pneumonectomy in pulmonary metastases?1

Isabella Rohrer-Gubler, Urs Niederhauser, Marko I Turina

Aortopulmonary window with anomalous origin of the right coronary artery Jürg Grünenfelder, MD, Gregor Zünd, MD, Paul R Vogt, MD, Marko I Turina, MD

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery Gabriella Lindvall, MD, Ulrik Sartipy, MD, PhD, Torbjörn.

Neal S Goldstein, MD The Annals of Thoracic Surgery

Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit Michael J Ray, PhD, Majella M Hales,

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Reduced inotropic support after aprotinin therapy during pediatric cardiac operations Carl F Wippermann, MD, Franz X Schmid, MD, Balthasar Eberle, MD,

Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery William C Oliver, MD, David N Fass, PhD, Gregory A Nuttall,

Treatment of left atrial dissection after mitral repair: internal drainage Michele Genoni, MD, Rolf Jenni, MD, Edith R Schmid, MD, Paul R Vogt, MD, Marko.

The use of routine chest x-ray films after chest tube removal in postoperative cardiac patients James T McCormick, DO, Michael S O’Mara, MD, Pavlos K.

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts Paul R Vogt, MD, Marko I Turina, MD The Annals.

Roderick W Landymore, MD, Alexander J Bayes, MD, J

Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations Martin Misfeld, MD, Sven Dubbert, Sawas Eleftheriadis,

Adnan Cobanoglu, MD, Jess M Schultz, MD The Annals of Thoracic Surgery

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass

The Impact of New Technology on Cardiothoracic Surgical Practice

Aortic root replacement versus aortic valve replacement: a case-match study Paul P Urbanski, MD, Matthias Wagner, MD, Michael Zacher, MD, Robert W Hacker,

Influence of High- and Low-Dose Aprotinin on Activation of Hemostasis in Open Heart Operations Wulf Dietrich, Karl Schöpf, Michael Spannagl, Marianne.

Robert J Frumento, MS, MPH, Catherine M

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass Peter Raivio, MD, Jari Petäjä,

Paul Philipp Heinisch, MD, Thierry Carrel, MD

High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations Balthasar Eberle, Eckhard Mayer, Gerhard.

Presentation transcript:

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD, Paul R Vogt, MD, Marko I Turina, MD The Annals of Thoracic Surgery Volume 66, Issue 1, Pages 153-158 (July 1998) DOI: 10.1016/S0003-4975(98)00396-8

Fig 1 Concentrations of total degradation products of fibrin-fibrinogen and d-dimers 15 minutes after cardiopulmonary bypass. A dose-dependent reduction was observed under high-dose aprotinin compared with low-dose and control patients. The Annals of Thoracic Surgery 1998 66, 153-158DOI: (10.1016/S0003-4975(98)00396-8)